Literature DB >> 3464041

A comparison of the contractile activity of PGD2 and PGF2 alpha on human isolated bronchus.

J L Black, C L Armour, K S Vincenc, P R Johnson.   

Abstract

Prostaglandins may be implicated in the bronchoconstriction which occurs in asthma. Prostaglandins F2 alpha (PGF2 alpha) and D2 (PGD2) have been reported to produce bronchoconstriction in asthmatic subjects in vivo and PGF2 alpha contracts human isolated airway smooth muscle. We examined the relative efficacy and potency of PGF2 alpha and PGD2 on human bronchial spiral strips taken from 6 patients at thoracotomy. PGF2 alpha had greater efficacy than PGD2. The mean % Tmax (percentage of maximal contractile response) +/- s.e. mean were 84 +/- 7 and 54 +/- 7 respectively (P less than 0.05). PGF2 alpha (mean pD2 +/- s.e. mean = 6.39 +/- 0.6) tended to be more potent than PGD2 (5.68 +/- 0.2). Since, in vivo, PGD2 has greater efficacy and potency than PGF2 alpha, our results suggest that the in vivo effect of these prostaglandins does not result solely from an action on airway muscle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464041     DOI: 10.1016/0090-6980(86)90139-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  5 in total

1.  The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.

Authors:  S Hamid-Bloomfield; A N Payne; A A Petrovic; B J Whittle
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

Review 2.  Patient Stratification in Sepsis: Using Metabolomics to Detect Clinical Phenotypes, Sub-Phenotypes and Therapeutic Response.

Authors:  Humma Hussain; Kritchai Vutipongsatorn; Beatriz Jiménez; David B Antcliffe
Journal:  Metabolites       Date:  2022-04-21

3.  Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors.

Authors:  R A Coleman; R L Sheldrick
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig.

Authors:  H P Francis; S J Greenham; U P Patel; A M Thompson; P J Gardiner
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

5.  Nasal hyperreactivity and inflammation in allergic rhinitis.

Authors:  I M Garrelds; C de G Veld; R G Wijk; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.